In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

President Trump is doubling down on drug tariffs, saying they'll likely kick in by August 1. Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to explain how companies like ...

By Miranda Murray and Patricia Weiss BERLIN (Reuters) -Swiss drugmaker Novartis nudged up its full-year earnings forecast on ...

President Donald Trump says that he was likely to impose tariffs on pharmaceuticals as soon as the end of this month.

Anticipating potential tariffs on South Korean goods, particularly cosmetics, U.S. consumers are stocking up on K-beauty ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.

States lost $2.3 billion in Medicaid drug rebates in 2024 due to the expanded 340B program, with Pennsylvania, Illinois, and Massachusetts hit hardest.

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year ...

Early trading on Wall Street was quietly mixed as markets shift their attention toward a deluge of corporate earnings reports ...

By Noreen Marcus, FloridaBulldog.org - Trump’s tariff assault on drug affordability stings a Vero Beach cancer patient ...